Conflu3nce

Personalized Solution for Detecting Cognitive Health Changes

Health Tech & Life Sciences
Active
Pre-Seed Jerusalem, Israel Founded 2016
Last updated 2026-06-18
Total raised
$330K
Last: Grant 2020-03
Stage
Pre-Seed
Founded
2016
Headcount
1
HQ
Jerusalem, Israel
Sector
Health Tech & Life Sciences

About

Conflu3nce applies its patented methods to the early detection of cognitive health changes in people across the cognitive spectrum. The company is developing PICSSi, a minimally-disruptive, on-demand system that addresses cognitive-motor issues for people across a wide range of ages and conditions, including Alzheimers disease, traumatic brain injury, Parkinsons disease, stroke, and attention-deficit/hyperactivity disorder. The systems multi-modal, multi-domain-based personalized interactive units are designed to cooperatively engage global cognition and can be delivered as hands-on or virtual/view-only experiences. The company's PICSSi and Stitch and Peel (SnP) technology is based on processes and methods that use content-rich, dynamic, 3D-like figure-ground image sets with image properties that can be manipulated and predicted. For early detection, PICSSi can be personalized to capture an individuals cognitive expression pattern without bias toward disease/symptom trajectories or domain-specific deficits. User-specific baselines are used to detect changes in cognition over time. And for training/remediation, users are guided through increasingly challenging interactions to develop and retrain their skills, processes, and processing based on their dynamic progress.

Funding history · 2 rounds · $330K total

2020-03
2018-03
$300K

Q&A

What is Conflu3nce's primary focus?
Conflu3nce focuses on the early detection of cognitive health changes using patented methods and is developing PICSSi, a system for cognitive-motor issues.
What technology does Conflu3nce utilize for its solutions?
Conflu3nce's PICSSi and Stitch and Peel (SnP) technology is based on processes and methods that use content-rich, dynamic, 3D-like figure-ground image sets with manipulable and predictable image properties.
When was Conflu3nce founded?
Conflu3nce was founded in April 2016.
How many employees does Conflu3nce currently have?
Conflu3nce has 1-10 employees.
What is Conflu3nce's total funding to date?
Conflu3nce has raised a total of $330,000 USD.
When was Conflu3nce's last funding round and who participated?
Conflu3nce's last funding round was a Grant in March 2020, with participation from Jerusalem Development Authority.
Who is the Founder and CEO of Conflu3nce?
Tami Ellison is the Founder & CEO of Conflu3nce.
Does Conflu3nce hold any patents?
Yes, Conflu3nce holds 1 patent.

Team · 1

Founder · Founder & CEO
LinkedIn ↗

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesDigital HealthcareDigital Therapeutics
Technologies
Artificial IntelligenceComputer VisionPlatforms & InterfacesSoftwareSimulation & Imaging
Target customers
Healthcare & Life SciencesHealthcarePatients
Business model
B2BB2CB2B2C

Highlights

1 PatentsVerified

Tags

neurology3d-technologyneuro-stimulationalzheimers-diseaseinsurance-companiesnon-invasiveparkinsonmedical-devicesearly-detectioncomputer-visionartificial-intelligencehealthcare-providersmobile-applicationsseniorshospitalspharma-companiesdiagnosticstrainingdigital-healthcareadhddegenerative-diseasescognitive-trainingtreatmentsimage-processingdigital-therapeuticsrehabilitation
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)